JHS Svendgaard Laboratories Ltd's Q3FY25 Quarter Results
- 12 Feb 2025
Result Summary
- JHS Svendgaard Laboratories Ltd reported a 11.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 37.8%.
- Its expenses for the quarter were up by 8.4% QoQ and 52.3% YoY.
- The net profit decreased 82.2% QoQ and decreased 18500.0% YoY.
- The earnings per share (EPS) of JHS Svendgaard Laboratories Ltd declined at 0.2 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 22.93 | 20.54 | 16.64 | 11.6% | 37.8% |
Total Expenses | 24.51 | 22.62 | 16.09 | 8.4% | 52.3% |
Profit Before Tax | -1.58 | -2.07 | 0.55 | -23.7% | -387.3% |
Tax | 0.25 | 8.25 | 0.54 | -97.0% | -53.7% |
Profit After Tax | -1.84 | -10.32 | 0.01 | -82.2% | -18500.0% |
Earnings Per Share | -0.20 | -1.20 | 0.00 | -83.3% | - |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
JHS Svendgaard Laboratories Ltd is a company involved in the oral care industry, primarily engaged in the manufacturing of dental and oral hygiene products. The company produces a range of products including toothbrushes, toothpastes, and other oral care items under both its own brands and for third parties. Located in India, JHS Svendgaard operates in a competitive market, catering to both domestic and international clients. Any recent major developments about the company are not available within the provided data.
Revenue
The total income for JHS Svendgaard Laboratories Ltd in Q3FY25 was ₹22.93 crores, reflecting an increase from ₹20.54 crores in Q2FY25 and ₹16.64 crores in Q3FY24. This represents a quarter-over-quarter (QoQ) growth of 11.6% and a year-over-year (YoY) increase of 37.8%. The observed growth in total income suggests an upward trend in revenue generation over both the quarter and the year.
Profitability
In Q3FY25, JHS Svendgaard Laboratories Ltd reported a loss, with a profit before tax (PBT) of -₹1.58 crores, compared to -₹2.07 crores in Q2FY25 and a profit of ₹0.55 crores in Q3FY24. The QoQ change in PBT was a decrease of 23.7%, while the YoY change was -387.3%. The company incurred a tax of ₹0.25 crores in Q3FY25, significantly lower than the ₹8.25 crores in Q2FY25 and ₹0.54 crores in Q3FY24, representing a -97.0% QoQ change and -53.7% YoY change. The profit after tax (PAT) for Q3FY25 was -₹1.84 crores, improving from -₹10.32 crores in Q2FY25 but down from ₹0.01 crores in Q3FY24, with a QoQ change of -82.2% and a YoY change of -18500.0%.
Operating Metrics
The earnings per share (EPS) for JHS Svendgaard Laboratories Ltd in Q3FY25 was -₹0.20, an improvement from -₹1.20 in Q2FY25, with a QoQ change of -83.3%. No YoY percentage change is available for the EPS as the EPS was reported as ₹0.00 in Q3FY24. These operating metrics indicate fluctuations in the financial performance over the reported periods, with notable improvements in QoQ metrics despite negative values.
